By setting new facilities within the cancer center “Institut Bergonié”, Explicyte – in addition to its preclinical research capabilities – strengthens its development towards clinical translational research, to provide new services based on multiparametric experimental biomarker analysis, for target identification and monitoring of the immune response in the context of clinical trials.
If you attend the ASCO Annual Meeting this year in Chicago, we will be glad to take this opportunity to meet you there and discuss the way Explicyte can support your clinical research programs.
